Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Heimbach

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Applied Microbiology and Biotechnology|November 1, 1991
Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 proteaseW K Herber, F J Bailey, C E Carty, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Affinity purification of the HIV-1 proteaseJ C Heimbach, V M Garsky, S R Michelson, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
The Journal of Biological Chemistry|February 5, 1989
Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic proteaseP L Darke, C T Leu, L J Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Active human immunodeficiency virus protease is required for viral infectivityN E Kohl, E A Emini, W A Schleif, et al.
The Journal of Biological Chemistry|August 25, 1990
Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolutionP M Fitzgerald, B M McKeever, J F VanMiddlesworth, et al.
The Journal of Biological Chemistry|February 5, 1989
Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1B M McKeever, M A Navia, P M Fitzgerald, et al.
Nature|February 16, 1989
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1M A Navia, P M Fitzgerald, B M McKeever, et al.
Journal of Medicinal Chemistry|July 20, 1992
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activityT J Tucker, W C Lumma, L S Payne, et al.
Vaccine: X|May 3, 2021
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike proteinJillian M DiMuzio, Baron C Heimbach, Raymond J Howanski, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Applied Microbiology and Biotechnology|November 1, 1991
Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 proteaseW K Herber, F J Bailey, C E Carty, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Affinity purification of the HIV-1 proteaseJ C Heimbach, V M Garsky, S R Michelson, et al.
Deutsche Medizinische Wochenschrift (1946)|September 26, 2003
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]K Frank-Raue, C Heimbach, S Rondot, et al.
The Journal of Biological Chemistry|February 5, 1989
Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic proteaseP L Darke, C T Leu, L J Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Active human immunodeficiency virus protease is required for viral infectivityN E Kohl, E A Emini, W A Schleif, et al.
The Journal of Biological Chemistry|August 25, 1990
Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolutionP M Fitzgerald, B M McKeever, J F VanMiddlesworth, et al.
The Journal of Biological Chemistry|February 5, 1989
Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1B M McKeever, M A Navia, P M Fitzgerald, et al.
Nature|February 16, 1989
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1M A Navia, P M Fitzgerald, B M McKeever, et al.
Journal of Medicinal Chemistry|July 20, 1992
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activityT J Tucker, W C Lumma, L S Payne, et al.
Vaccine: X|May 3, 2021
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike proteinJillian M DiMuzio, Baron C Heimbach, Raymond J Howanski, et al.
Pageof 2